 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: OCREVUS (ocrelizumab) |
|
***************************************************** |
|
#Post#: 4464-------------------------------------------------- |
|
Subcutaneous Ocrevus gets EU approval |
|
By: agate Date: June 26, 2024, 12:57 am |
|
--------------------------------------------------------- |
|
From Morningstar (June 24, 2024)--"Roche's Multiple Sclerosis |
|
Injection Gets EU Approval": |
|
https://www.morningstar.com/news/dow-jones/20240625262/roches-multiple-sclerosi… |
|
And from European Pharmaceutical Review (June 25)--New multiple |
|
sclerosis treatment option granted in EU": |
|
https://www.europeanpharmaceuticalreview.com/news/230766/new-multiple-sclerosis… |
|
#Post#: 4483-------------------------------------------------- |
|
(The Guardian) MS patients in England offered 10-minute jab in p |
|
lace of infusions |
|
By: agate Date: July 13, 2024, 12:37 am |
|
--------------------------------------------------------- |
|
Looks as if the UK will be offering Ocrevus as 10-minute, |
|
hospital-administered injections. |
|
From The Guardian (July 12, 2024)--"MS patients in England |
|
offered 10-minute jab in place of infusions": |
|
https://www.theguardian.com/society/article/2024/jul/12/multiple-sclerosis-engl… |
|
***************************************************** |
